• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Minocycline and doxycycline kinetics in chronic renal failure.

作者信息

Heaney D, Eknoyan G

出版信息

Clin Pharmacol Ther. 1978 Aug;24(2):233-9. doi: 10.1002/cpt1978242233.

DOI:10.1002/cpt1978242233
PMID:679601
Abstract
摘要

相似文献

1
Minocycline and doxycycline kinetics in chronic renal failure.
Clin Pharmacol Ther. 1978 Aug;24(2):233-9. doi: 10.1002/cpt1978242233.
2
[Activity in vitro and pharmacokinetics of minocycline (author's transl)].米诺环素的体外活性及药代动力学（作者译）
Arzneimittelforschung. 1976 Apr;26(4):556-60.
3
Clinical pharmacokinetics of doxycycline and minocycline.
Clin Pharmacokinet. 1988 Dec;15(6):355-66. doi: 10.2165/00003088-198815060-00001.
4
[Minocycline and doxycycline concentrations in the serum, urine, prostatic fluid and prostatic tissue].
Fortschr Med. 1982 Apr 8;100(13):605-8.
5
[Doxycycline pharmacokinetics in chronic kidney failure patients treated by hemodialysis].[血液透析治疗的慢性肾衰竭患者的多西环素药代动力学]
Ann Acad Med Stetin. 1981;27:313-30.
6
Pharmacokinetics of minocycline in renal failure.米诺环素在肾衰竭中的药代动力学。
Antimicrob Agents Chemother. 1975 Nov;8(5):532-7. doi: 10.1128/AAC.8.5.532.
7
One-dose and multiple-dose kinetics of minocycline in patients with renal disease.
Agents Actions. 1977 Sep;7(3):369-77. doi: 10.1007/BF01969570.
8
[Pharmacokinetic studies of Minocycline in patients with chronic kidney failure either treated or not treated by hemodialysis].
Lille Med. 1974 Mar;19(3):287-92.
9
Metal ion-tetracycline interactions in biological fluids. 2. Potentiometric study of magnesium complexes with tetracycline, oxytetracycline, doxycycline, and minocycline, and discussion of their possible influence on the bioavailability of these antibiotics in blood plasma.生物流体中的金属离子 - 四环素相互作用。2. 镁与四环素、土霉素、强力霉素和米诺环素络合物的电位滴定研究，以及它们对这些抗生素在血浆中生物利用度可能影响的讨论。
J Inorg Biochem. 1983 Aug;19(1):1-18. doi: 10.1016/0162-0134(83)85009-0.
10
[Tetracyclines for the treatment of mycoplamic prostato-urethritis].
MMW Munch Med Wochenschr. 1976 Jan 9;118(2):49-50.

引用本文的文献

1
Pharmacokinetic Profile of Doxycycline in Koala Plasma after Weekly Subcutaneous Injections for the Treatment of Chlamydiosis.每周皮下注射强力霉素治疗考拉衣原体病后，强力霉素在考拉血浆中的药代动力学特征。
Animals (Basel). 2022 Jan 20;12(3):250. doi: 10.3390/ani12030250.
2
Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class.口服四环素类药物在成年社区获得性细菌性肺炎患者治疗中的应用：对这一常被忽视的抗生素类别的文献综述
Antibiotics (Basel). 2020 Dec 14;9(12):905. doi: 10.3390/antibiotics9120905.
3
Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.
强力霉素-利福平相互作用对布鲁氏菌病治疗的潜在影响。
Antimicrob Agents Chemother. 1994 Dec;38(12):2798-802. doi: 10.1128/AAC.38.12.2798.
4
Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.药物动力学特性的差异：对肾衰竭患者选用特定药物的意义，特别强调抗生素和β-肾上腺素能受体阻滞剂。
Clin Pharmacokinet. 1980 Sep-Oct;5(5):441-64. doi: 10.2165/00003088-198005050-00003.
5
Clinical pharmacokinetics of doxycycline and minocycline.
Clin Pharmacokinet. 1988 Dec;15(6):355-66. doi: 10.2165/00003088-198815060-00001.
6
Guide to drug dosage in renal failure.肾衰竭药物剂量指南。
Clin Pharmacokinet. 1988 Nov;15(5):326-54. doi: 10.2165/00003088-198815050-00005.
7
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.肾功能受损患者抗生素的临床药代动力学
Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002.
8
Minocycline-induced interstitial nephritis.米诺环素诱导的间质性肾炎。
Br Med J. 1979 Mar 24;1(6166):820-1. doi: 10.1136/bmj.1.6166.820-e.